The importance of hemoglobinopathy screening in newborns

Hemoglobinopathies, including sickle cell disease and thalassemias, are among the most common inherited blood disorders worldwide. Early detection through newborn screening is critical for initiating timely interventions that can significantly improve health outcomes and reduce morbidity and mortality. This webinar will explore the clinical significance of hemoglobinopathy screening in newborns, review current screening methodologies, and discuss global strategies for implementing effective screening programs. Attendees will gain valuable insights into the benefits of early diagnosis and the role of public health initiatives in managing these conditions from infancy.